Covid: Oxford vaccine shows 'encouraging' immune response in older adults

CHINA Chinese experimental vaccine induces a quick response

A third phase of testing among a larger group of people is underway and early results are expected in the coming weeks.

After reporting strong antibody levels in Phase 2 trials, Moderna and Pfizer in recent days announced preliminary Phase 3 efficacy rates above 90 percent, a result greeted with enthusiasm from the medical world.

The ongoing pandemic has seen numerous countries race for an effective vaccine against COVID-19, with Sinovac running phase 3 trials in Brazil, Indonesia and Turkey, Reuters reported.

The Pfizer vaccine is now furthest ahead and Albert Bourla, the chief executive of the pharmaceutical company, said submissions to regulators would be made within days and shipping would begin "a couple of hours" after it was given the green light.

Sinopharm's vaccines, which use inactivated virus unable to replicate in human cells to trigger immune responses, require two doses, clinical trial registration data showed.

Phase 1 and 2 trials are not created to show efficacy, says Dr. Kirsten Lyke, an immunologist and medical professor at the University of Maryland School of Medicine.

CoronaVac is one of the 48 vaccine candidates for Covid-19 that are now in clinical trials.


The Oxford-AstraZeneca COVID-19 vaccine candidate, called AZD1222 or ChAdOx1 nCoV-19, had been among the front-runners in global efforts to develop shots to protect against infection with the novel coronavirus, or SARS-CoV-2.

They show that older adults aged 56-69 and over 70 had a similar immune response to younger adults aged 18-55.

According to the study, stronger antibody responses were produced with doses given on day 0 and 28 of the trial.

Volunteers in the trial were put into groups and given one or two doses of the vaccine or a dummy jab.

These trial results from the University of Oxford, peer-reviewed in the Lancet, suggest that may not be a problem. It said one person had a severe reaction of hives and recovered within three days with treatment. This is the last stage before seeking regulatory approval, and includes tracking the effectiveness of the vaccine in preventing coronavirus. The companies, Moderna and Pfizer, have said they will seek emergency use authorization for their vaccines from the U.S. Food and Drug Administration (FDA).

Prof Andrew Hayward - director of the UCL Institute of Epidemiology and Health Care and a member of the government's Scientific Advisory Group for Emergencies - told the BBC that family gatherings at Christmas would pose "substantial risks".

Related:

Comments

Latest news

Tom Holland & Daisy Ridley's Star-Studded Movie 'Chaos Walking' Debuts Official Trailer
However, they're also trying to escape a risky and disorienting reality, where all inner thoughts are seen and heard by everyone. The new trailer for Chaos Walking starring Spider-Man himself, Tom Holland and Star Wars' Rey, Daisy Ridley , has been released.

BBC Radio 1 to play edited version of 'Fairytale Of New York'
Last year, the BBC defended using the original version of Fairytale of NY in the Gavin & Stacey Christmas special. The popular Christmas track contains a homophobic slur, which the BBC have chose to change.

California Medical Association officials attended French Laundry dinner party with Gavin Newsom
Gavin Newsom at a top California political operative's opulent birthday dinner at the French Laundry restaurant this month. However, the state has intentionally allowed restaurants to seat people from more than three households together.

Hoot, hoot, hoot! Owl in Rockefeller Center Christmas tree
The bird, nicknamed Rockefeller, will be released back into the wild in the coming days. The owl was then taken to the wildlife center to be checked out.

Leonids meteor shower to peak this week
Because the Leonid Meter Shower Meter will be more visible in North Godhar, it will also be visible to the naked eye in India. For the uninformed, the Leonids emerge from the comet Tempel-Tuttle, which requires 33 years to revolve once around the Sun.

Other news